CME REVIEW ARTICLE
Assessment of asthma control and severity

https://doi.org/10.1016/S1081-1206(10)61406-8Get rights and content

Objective

To provide a conceptual framework for defining severity and control in asthma, to describe recent advances in measuring asthma control, and to discuss the role of severity and control in asthma disease management.

Data Sources

MEDLINE was searched for relevant English-language articles published between 1998 and July 2003. Additional sources included key references cited in these articles, national and international guidelines for the diagnosis and management of asthma, and the author's personal bibliography.

Study Selection

All studies that reported on the development and validation of formal measures of asthma control, as well as the few editorials that focused on the distinction between asthma severity and control, were included. The author's professional judgment was used to select for illustrative purposes from among the many purported measures of asthma severity in the literature.

Results

Although several standardized measures of asthma control exist, no direct comparisons of the performance and properties of these control measures have been published. The available instruments appear more similar than dissimilar. All share the common trait of assessing multiple aspects of asthma control, which is believed to provide better discrimination than a single measure.

Conclusions

Asthma control is different from asthma severity and may be useful as a clinical vital sign for patients with asthma. Ultimately, no one measure may be better than any of the others or the optimal measure may depend on the intended use of the scale.

REFERENCES (26)

  • National Institutes of Health, National Asthma and Education and Prevention Program

    Clinical Practice Guidelines: Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma

    (1997)
  • National Institutes of Health, Global Initiative for Asthma

    Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report

    (1995)
  • National Institutes of Health
  • Cited by (0)

    This feature is supported by an unrestricted educational grant from AstraZeneca LP

    View full text